PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING INFLAMMATORY DISEASES, CONTAININGLACTOCOCCUS CHUNGANGENSIS
    8.
    发明公开
    PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING INFLAMMATORY DISEASES, CONTAININGLACTOCOCCUS CHUNGANGENSIS 审中-公开
    用于预防或治疗炎性疾病的药物组合物,含有肺孢子虫

    公开(公告)号:EP3275450A2

    公开(公告)日:2018-01-31

    申请号:EP16773374.0

    申请日:2016-03-25

    IPC分类号: A61K35/74 A61K35/742

    摘要: The composition according to the present invention, which comprises Lactococcus chungangensis as an active ingredient, has excellent effects of preventing or treating inflammatory diseases, inhibiting the secretion of nitric oxide and prostaglandin E 2 , which are major inflammatory factors, and inhibiting the secretion of β-hexosaminidase and histamine, which are major factors related to allergies, and also significantly suppressing the production of skin disease-related cytokines and chemokines. Such effects are at the same level as those of conventional skin disease therapeutic agents (tacrolimus), and thus the composition can be used as a preventive or therapeutic agent against inflammatory diseases. In addition, the composition according to the present invention exhibits an antibacterial activity against Staphylococcus aureus, which is a microorganism inducing a secondary infection of atopic dermatitis and the like, and thus can be used in preventing or treating a bacterial infection.

    摘要翻译: 本发明的含有乳酸球菌作为活性成分的组合物具有预防或治疗炎性疾病,抑制作为主要炎症因子的一氧化氮和前列腺素E2的分泌, 氨基己糖苷酶和组胺,它们是与变态反应有关的主要因素,并且也显着抑制皮肤病相关细胞因子和趋化因子的产生。 这些效果与常规皮肤疾病治疗剂(他克莫司)的效果相同,因此该组合物可以用作针对炎性疾病的预防或治疗剂。 另外,本发明的组合物对作为诱发特应性皮炎等的继发感染的微生物的金黄色葡萄球菌表现出抗菌活性,因此可用于预防或治疗细菌感染。

    PROTEIN TRANSDUCTION DOMAIN BASED ON GOLD NANOPARTICLE-APTAMER CONJUGATE AND METHOD FOR PRODUCING SAME
    9.
    发明公开
    PROTEIN TRANSDUCTION DOMAIN BASED ON GOLD NANOPARTICLE-APTAMER CONJUGATE AND METHOD FOR PRODUCING SAME 审中-公开
    蛋白转导基于其制造GOLDNANOPARTIKELAPTAMERKONJUGATS和方法

    公开(公告)号:EP2995300A1

    公开(公告)日:2016-03-16

    申请号:EP13875242.3

    申请日:2013-12-19

    摘要: The present invention relates to a protein transduction domain comprising gold nanoparticles and aptamers binding to the surfaces of the gold nanoparticles. The protein transduction domain according to the present invention is expected to be useful for diagnosing or treating diseases since the protein transduction domain specifically binds to proteins, which are to be delivered by various tagged aptamers or protein-specific aptamers binding to gold nanoparticles, thereby effectively delivering the proteins into cells, can be harmless to humans by using gold nanoparticles having very little cytotoxicity, and allows easy confirmation of the intercellular position thereof by reflecting lights of various wavelengths.

    摘要翻译: 本发明涉及一种蛋白质转导结构域包含金纳米颗粒和适体结合的金纳米颗粒的表面上。 蛋白转导域雅丁到,本发明预期可用于诊断或治疗疾病,因为所述蛋白转导结构域特异性结合蛋白,其是通过各种标记的适体或蛋白质特异性的适体结合的金纳米颗粒被输送,从而有效地有用 递送蛋白到细胞中,可以通过使用具有非常小的细胞毒性的金纳米颗粒对人体无害,并且其通过反映各种波长的光允许细胞间位置的容易确认。

    COMPOSITION FOR PREVENTING OR TREATING VASCULAR DISEASES, CONTAINING HAPLN1

    公开(公告)号:EP4349364A1

    公开(公告)日:2024-04-10

    申请号:EP22816408.3

    申请日:2022-05-30

    发明人: KIM, Dae Kyong

    IPC分类号: A61K38/17 A61P9/00 A23L33/17

    摘要: The present invention relates to a composition for repairing vascular degeneration and vascular injuries and preventing or treating vascular diseases, containing hyaluronan and proteoglycan link protein 1 (HAPLN1) as an active ingredient. More specifically, provided is a pharmaceutical composition and a health functional food composition for preventing or treating vascular diseases, containing HAPLN1 as an active ingredient. HAPLN1 inhibits and alleviates, in blood vessel walls, damage to the elastin fiber layer and loss of transgelin, and effectively inhibits the phosphorylation of NF-κB or focal adhesion kinase (FAK) in vascular smooth muscle cells (VSMCs), and thus can be used for preventing, alleviating or treating vascular injuries and various diseases caused by aging or a high-fat diet.